DIVE Medical introduced the TrackAI solution to diagnose vision impairment in children

At VivaTech, Huawei is hosting a demonstration of the TrackAI solution at its stand; developed in Spain by the IIS Aragon institute and the start-up DIVE Medical with the technological support of Huawei, TrackAI protects the vision of children from the age of 6 months

PARIS-(BUSINESS WIRE)-Huawei has put its artificial intelligence expertise at the service of IIS Aragon medical research institute and DIVE Medical to develop Track AIan AI -based assessment system that detects and evaluates early signs of visual impairment in children.

The World Health Organization (WHO) estimates that every day 11,000 babies are born with visual impairment and approximately 810 million children worldwide are affected by eye diseases. Often these children are not diagnosed for many years, with serious consequences for their vision, development, and educational and social opportunities. Early diagnosis is important because rapid intervention can prevent or cure 9 out of 10 cases.

How does the TrackAI device work?

To diagnose visual impairments, DIVE (Devices for an Integral Visual Examination) software is run on a Huawei Matebook E tablet. Using the “eye tracking” technique, it tracks and monitors the gaze of each eye as the patient observes stimuli designed to test the visual. functions. Data collected from patients ’perception patterns is processed by a Huawei P30 smartphone running a pre-trained machine learning model powered by HiAI 2.0, Huawei’s Artificial Intelligence platform, to determine potential disability indicator.

Powered by Huawei smartphones and the Huawei HiAI 2.0 algorithm, the TrackAI is an easy-to-use, portable and affordable device that helps detect visual impairment problems early in children and infants as young as six months old. The goal is to make untrained people autonomous so that they can contribute to the detection of vision impairments, thus resolving the shortage of ophthalmologists.

“Our first goal was to offer a simple test with the ability to see within minutes which patients really need to be referred to a specialist. At TrackAI, we already have huge eye movement data from thousands -thousands of children, which allows us to distinguish between normal and abnormal thought patterns in real time, “ explained Marta Ortín, CTO of DIVE Medical.

Encouraging results

Developing an AI-based system requires the collection of anonymous data. Thus, the partner research centers have been collecting test data since 2019 through a multicenter study to train the Artificial Intelligence model in four countries: Spain, China, Vietnam and Mexico. Much information has been obtained on the visual development of children with neurocognitive disorders, which are particularly difficult to detect.

Data were actually collected on 4,500 children with visual impairment. This collection allowed to train the artificial intelligence neural network, to adjust the machine learning model and consequently refine the tracking capabilities of TrackAI.

Finding partners in France

DIVE Medical seeks to expand its network of partner research centers in Africa and Europe because the more anonymous data collected, the more relevant TrackAI is to its evaluations. France, which has many modern ophthalmology establishments, is privileged. DIVE Medical is currently looking for a partner there to conduct 400 screenings and contribute to the prevention of vision diseases in children and infants over 6 months old.

contacts

Media contacts

Patricia Goldman International for Huawei France:
Simon Labouyrie

slabouyrie@patricia-goldman.com

Juliette Guemas

jguemas@patricia-goldman.com

Charles Catherinot, Huawei France
charles.catherinot@huawei.com

Michelle Lizhuoran, Huawei France
lizhuoran4@huawei.com

Source: http: //www.businesswire.com/news/home/202206150057 …

Leave a Comment